TRADING ON THE OTC - SYMBOL : PGUZ
OUR PRODUCTS : MEDICAL BACKGROUND & RESEARCH DATA : MANAGEMENT : INVESTORS/NEWS : LINKS : CONTACT US


CLICK HERE TO DOWNLOAD
AN INVESTOR’S GUIDE
TO
PEGASUS PHARMACEUTICALS

 

Home Page  |  
 


THE HEARTVUE 6S SYSTEM IS A SUPERIOR SCREENING SYSTEM FEATURING NON-INVASIVE SCREENING FOR HEART DISEASE. IT PROVIDES A QUICK, 3-D COLORED IMAGE OF THE HEART.


Ischemic Heart Disease : Results of Coronarography

The HeartVue 6S System provides a quick (1-2 minutes) and accurate assessment of patients with suspected coronary artery disease. The device uses only 4 standard electrodes and a dispersion mapping method analysis of low amplitude ECG signals to detect heart abnormalities and ischemia. The results are then presented as a color-coded, 3-dimensional digital heart map which reflects electrical dispersions.

The device allows the tester to observe the condition of the heart muscle, as well as the intensity of the heart stress load. The test uses new information from ECG fluctuations that are usually ignored as "noise" by regular ECG devices. An image of the patient's heart, along with an electrocardiogram are produced. The HeartVue 6S System will be an invaluable screening tool for cardiologists, general practitioners, clinics, hospitals, the fitness industry, sports teams and emergency medical facilities.

 



Pegasus Pharmaceutical’s Dr. Mongo non-toxic, biological
anti-mold & mildew product line to be introduced to
the Mexican market by Tenax Corporation.

 

The HeartVue™ 6S System is the product of a joint venture between Pegasus Pharmaceuticals Inc. and Heartview LLC, a Cleveland, Ohio-based company which holds the worldwide patent, manufacturing and marketing rights of this innovative heart-screening system. An earlier version of the HeartVue 6S System has been cleared for sale in Europe and there is a patent pending for the ECV device in the United States. Pegasus Pharmaceuticals Inc. has acquired a majority control of Heartview LLC.


Copyright © 2006, Pegasus Pharmaceuticals Inc.